BioCV Denmark ApS: Financial statements 2025
CVR: 43088742
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioCV Denmark ApS (CVR 43088742) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -386,126 and a net result of DKK -585,336 compared with DKK -666,047 the year before. Equity in the 2025 report amounted to DKK -1,292,859. The company had 1 employee in the financial year.
- Gross Profit
- DKK -386,126
- Profit/Loss
- DKK -585,336
- Equity
- DKK -1,292,859
- Total Assets
- DKK 1,762,000
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -386 t. | -585 t. | -1.3 mio. | 1 |
| 2024 | - | -639 t. | -666 t. | -708 t. | 1 |
| 2023 | - | -182 t. | -188 t. | -41 t. | 1 |
| 2022 | - | -28 t. | -29 t. | 11 t. | 1 |
Official annual report
How creditworthy is BioCV Denmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioCV Denmark ApS has published its annual report for 2024. Gross profit came to DKK -639,032, and the net result was DKK -666,047.
About BioCV Denmark ApS
BioCV Denmark ApS is a Danish company of the type Anpartsselskab based in Tjele, founded in 2022. The company is registered under the industry Computerprogrammering. The management consists of Moritz Marvin Gansel. The company is owned by BioCV GmbH. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -386,126 and a net result of DKK -585,336 compared with DKK -666,047 the year before. Equity in the 2025 report amounted to DKK -1,292,859.